{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:20:35Z","timestamp":1760574035898,"version":"build-2065373602"},"reference-count":89,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The absence of universal diagnosis and treatment recommendations for congenital hypothyroidism (CH) has led to suboptimal diagnostic and therapeutic outcomes. This study aimed to provide immunologically relevant evidence for the diagnosis and treatment of CH.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Datasets related to CH were selected. Differentially expressed genes were screened, followed by enrichment analysis, weighted gene coexpression network analysis (WGCNA), protein\u2013protein interaction analysis, and machine learning for the identification of hub genes. The reliability of these hub genes was verified through least absolute shrinkage and selection operator (LASSO) regression, box plot comparison, and receiver operating characteristic (ROC) curve analysis. Through gene set enrichment analysis (GSEA) of coexpressed genes, the common pathways of the hub genes and the inflammatory factors involved were identified. Immunoinfiltration analysis was carried out to verify the immunological correlation. Inflammatory factors and immune cells were screened by batch Mendelian randomization. Finally, the reliability of the hub genes, their relationships with inflammatory factors, and their impacts on cell function and the synthesis of free thyroxine (FT4) were validated through real-time quantitative polymerase chain reaction (RT\u2013qPCR), enzyme-linked immunosorbent assay (ELISA), and cell proliferation experiments.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Multiomics analysis confirmed that APP, DDB1, MRPS5, and MRPL33 were hub genes with low expression levels in CH. These genes negatively regulated IL-2, and subsequently, through the STAT5 and MTORC1 pathways, they positively regulated (CD27 on IgD- CD38+ B cells) and (CD27 on switched memory B cells)\/CD244 and negatively regulated (CD33dim HLA DR+ CD11b- Absolute Count)\/IL-18 and (CD28+ CD4-CD8- T-cell %T cell)\/OPG, promoting the progression of CH. Increasing the expression levels of these hub genes could increase the activity of thyroid cells and promote the synthesis of FT4 through the abovementioned pathways.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>APP, DDB1, MRPS5, and MRPL33 regulate the expression of IL-2, act on relevant immune cell subtypes through the STAT5 and MTORC1 pathways, negatively regulate IL-18 and OPG, and positively regulate CD244, thereby influencing the activity of thyroid cells and the synthesis of FT4.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2025.1608098","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T05:43:53Z","timestamp":1760507033000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification of hub genes in congenital hypothyroidism and construction of the associated immune regulatory network"],"prefix":"10.3389","volume":"16","author":[{"given":"Mingliang","family":"Shan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenzhe","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiguo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1111\/cen.15110","article-title":"Paediatric thyroid disease","volume":"101","author":"Cheetham","year":"2024","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2011.160","article-title":"Detection and treatment of congenital hypothyroidism","volume":"8","author":"Gr\u00fcters","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1210\/er.2003-0028","article-title":"Thyroid development and its disorders: genetics and molecular mechanisms","volume":"25","author":"De Felice","year":"2004","journal-title":"Endocrine Rev"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2013.08.005","article-title":"Genetics of normal and abnormal thyroid development in humans","volume":"28","author":"Szinnai","year":"2014","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B5","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1089\/thy.2020.0333","article-title":"Congenital hypothyroidism: A 2020\u20132021 consensus guidelines update\u2014An ENDO-European reference network initiative endorsed by the European society for pediatric endocrinology and the european society for endocrinology","volume":"31","author":"van Trotsenburg","year":"2021","journal-title":"Thyroid"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2018.05.002","article-title":"Genetics and management of congenital hypothyroidism","volume":"32","author":"Persani","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/ncpendmet0424","article-title":"Thyroid hormone receptors in brain development and function","volume":"3","author":"Bernal","year":"2007","journal-title":"Nat Rev Endocrinol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2826.2008.01733.x","article-title":"Neurodevelopmental and neurophysiological actions of thyroid hormone","volume":"20","author":"Williams","year":"2008","journal-title":"J Neuroendocrinol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1136\/jmg.2004.024158","article-title":"Genetics of congenital hypothyroidism","volume":"42","author":"Park","year":"2005","journal-title":"J Med Genet"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0204323","article-title":"High frequency of mutations in \u201cdyshormonogenesis genes\u201d in severe congenital hypothyroidism","volume":"13","author":"Makretskaya","year":"2018","journal-title":"PloS One"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-1616","article-title":"Clinical review: Central hypothyroidism: pathogenic, diagnostic, and therapeutic challenges","volume":"97","author":"Persani","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1089\/thy.1999.9.661","article-title":"Maternal hypothyroidism: recognition and management","volume":"9","author":"Brent","year":"1999","journal-title":"Thyroid"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-21-0159","article-title":"Congenital hypothyroidism and thyroid cancer","volume":"28","author":"Penna","year":"2021","journal-title":"Endocr Relat Cancer"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djn471","article-title":"A germline mutation (A339V) in thyroid transcription factor-1 (TITF-1\/NKX2.1) in patients with multinodular goiter and papillary thyroid carcinoma","volume":"101","author":"Ngan","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1590\/S0004-27302008000900003","article-title":"Novos aspectos da gen\u00e9tica e dos mecanismos moleculares da morfog\u00eanese da tir\u00f3ide para o entendimento da disgenesia tiroidiana","volume":"52","author":"Ramos","year":"2008","journal-title":"Arq Bras Endocrinol Metab"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.860862","article-title":"Congenital hypothyroidism in preterm newborns \u2013 the challenges of diagnostics and treatment: A review","volume":"13","author":"Klosinska","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-18-0383","article-title":"DIAGNOSIS OF ENDOCRINE DISEASE: Congenital hypothyroidism: update and perspectives","volume":"179","author":"Peters","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1490247","article-title":"Primary congenital hypothyroidism: defects in iodine pathways","volume":"149","author":"de Vijlder","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1089\/thy.1999.9.735","article-title":"Congenital hypothyroidism: etiologies, diagnosis, and management","volume":"9","author":"LaFranchi","year":"1999","journal-title":"Thyroid"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1515\/jpem-2018-0197","article-title":"Congenital hypothyroidism","volume":"31","author":"Kiess","year":"2018","journal-title":"J Pediatr Endocrinol Metab"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.10.016","article-title":"Autoimmune thyroid disorders","volume":"14","author":"Antonelli","year":"2015","journal-title":"Autoimmun Rev"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2009.06.030","article-title":"Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease","volume":"123","author":"Boelaert","year":"2010","journal-title":"Am J Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1515\/jpem.1998.11.6.757","article-title":"Congenital hypothyroidism and immunodeficiency: evidence for an endocrine-immune interaction","volume":"11","author":"Pillay","year":"1998","journal-title":"J Pediatr Endocrinol Metab"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n2233","article-title":"Strengthening the reporting of observational studies in epidemiology using mendelian randomisation (STROBE-MR): explanation and elaboration","volume":"375","author":"Skrivankova","year":"2021","journal-title":"BMJ"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.18236","article-title":"Strengthening the reporting of observational studies in epidemiology using mendelian randomization: the STROBE-MR statement","volume":"326","author":"Skrivankova","year":"2021","journal-title":"JAMA"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2023.115660","article-title":"Mendelian-randomization study reveals causal relationships between nitrogen dioxide and gut microbiota","volume":"267","author":"Yang","year":"2023","journal-title":"Ecotoxicology Environ Saf"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2013.09.007","article-title":"Harmine induces apoptosis and inhibits tumor cell proliferation, migration and invasion through down-regulation of cyclooxygenase-2 expression in gastric cancer","volume":"21","author":"Zhang","year":"2014","journal-title":"Phytomedicine"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.00653","article-title":"Proliferating cell nuclear antigen (PCNA): a dancer with many partners","volume":"116","author":"Maga","year":"2003","journal-title":"J Cell Sci"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/path.1711620403","article-title":"Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: An index of cell proliferation with evidence of deregulated expression in some, neoplasms","volume":"162","author":"Hall","year":"1990","journal-title":"J Pathol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2005.07.002","article-title":"Bcl-2 antiapoptotic proteins inhibit beclin 1-dependent autophagy","volume":"122","author":"Pattingre","year":"2005","journal-title":"Cell"},{"key":"B31","article-title":"Stromal expression of 72 kda type IV collagenase (MMP-2) and TIMP-2 mRNAs in colorectal neoplasia","volume":"141","author":"Poulsom","year":"1992","journal-title":"PubMed"},{"key":"B32","article-title":"Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis","volume":"151","author":"Luca","year":"1997","journal-title":"Am J Pathol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"12827","DOI":"10.3390\/ijms222312827","article-title":"The MTT assay: utility, limitations, pitfalls, and interpretation in bulk and single-cell analysis","volume":"22","author":"Ghasemi","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1111\/bph.14554","article-title":"Amyloid precursor protein-mediated mitochondrial regulation and Alzheimer\u2019s disease","volume":"176","author":"Lopez Sanchez","year":"2019","journal-title":"Br J Pharmacol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a006288","article-title":"Physiological functions of APP family proteins","volume":"2","author":"M\u00fcller","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2018.03.032","article-title":"Inflammation, insulin signaling and cognitive function in aged APP\/PS1 mice","volume":"70","author":"Denver","year":"2018","journal-title":"Brain Behavior Immun"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/s41593-020-00796-z","article-title":"Fully defined human pluripotent stem cell-derived microglia and tri-culture system model C3 production in Alzheimer\u2019s disease","volume":"24","author":"Guttikonda","year":"2021","journal-title":"Nat Neurosci"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.80.12.8530592","article-title":"Thyroid epithelial cells produce large amounts of the Alzheimer beta-amyloid precursor protein (APP) and generate potentially amyloidogenic APP fragments","volume":"80","author":"Schmitt","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2011.09.001","article-title":"Damage-specific DNA binding protein 1 (DDB1): a protein with a wide range of functions","volume":"43","author":"Iovine","year":"2011","journal-title":"Int J Biochem Cell Biol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1186\/s13619-022-00119-6","article-title":"DDB1 maintains intestinal homeostasis by preventing cell cycle arrest","volume":"11","author":"Zhao","year":"2022","journal-title":"Cell Regener"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000474","article-title":"Hepatocyte-specific loss of DDB1 attenuates hepatic steatosis but aggravates liver inflammation and fibrosis in MASH","volume":"8","author":"Gu","year":"2024","journal-title":"Hepatol Commun"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02098-15","article-title":"Vpr enhances tumor necrosis factor production by HIV-1-infected T cells","volume":"89","author":"Roesch","year":"2015","journal-title":"J Virol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22052746","article-title":"Mitochondrial mistranslation in brain provokes a metabolic response which mitigates the age-associated decline in mitochondrial gene expression","volume":"22","author":"Shcherbakov","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1261\/rna.077347.120","article-title":"Mitochondrial misreading in skeletal muscle accelerates metabolic aging and confers lipid accumulation and increased inflammation","volume":"27","author":"Shcherbakov","year":"2021","journal-title":"RNA"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201846193","article-title":"Mutant MRPS5 affects mitoribosomal accuracy and confers stress-related behavioral alterations","volume":"19","author":"Akbergenov","year":"2018","journal-title":"EMBO Rep"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2017.314","article-title":"MRPL33 and its splicing regulator hnRNPK are required for mitochondria function and implicated in tumor progression","volume":"37","author":"Liu","year":"2018","journal-title":"Oncogene"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-023-01086-x","article-title":"Mitochondrial DNA-triggered innate immune response: mechanisms and diseases","volume":"20","author":"Hu","year":"2023","journal-title":"Cell Mol Immunol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1146\/annurev-biochem-032620-104401","article-title":"Mitochondrial DNA release in innate immune signaling","volume":"92","author":"Newman","year":"2023","journal-title":"Annu Rev Biochem"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1210\/en.2008-1145","article-title":"An inactivating mutation within the first extracellular loop of the thyrotropin receptor impedes normal posttranslational maturation of the extracellular domain","volume":"150","author":"Sura-Trueba","year":"2009","journal-title":"Endocrinology"},{"key":"B50","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1097\/MED.0000000000000181","article-title":"Congenital hypothyroidism: recent advances","volume":"22","author":"Wassner","year":"2015","journal-title":"Curr Opin Endocrinology Diabetes Obes"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-68-3-671","article-title":"Cytotoxic antibodies in congenital hypothyroidism","volume":"68","author":"Bogner","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"B52","unstructured":"STAT5 promotes PD-L1 expression by facilitating histone lactylation to drive immunosuppression in acute myeloid leukemia\n          \n          37777506"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-00888-3","article-title":"The ubiquitin ligase MDM2 sustains STAT5 stability to control T cell-mediated anti-tumor immunity","volume":"22","author":"Zhou","year":"2021","journal-title":"Nat Immunol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-007479","article-title":"TP53\/mTORC1-mediated bidirectional regulation of PD-L1 modulates immune evasion in hepatocellular carcinoma","volume":"11","author":"Yu","year":"2023","journal-title":"J Immunother Cancer"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1038\/s41467-023-36881-7","article-title":"mTORC1 upregulates B7-H3\/CD276 to inhibit antitumor T cells and drive tumor immune evasion","volume":"14","author":"Liu","year":"2023","journal-title":"Nat Commun"},{"key":"B56","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/978-1-4939-9424-3_2","article-title":"Mammalian NADPH oxidases","volume-title":"NADPH Oxidases: Methods and Protocols","author":"Buvelot","year":"2019"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aav1080","article-title":"IL-23 and IL-2 activation of STAT5 is required for optimal IL-22 production in ILC3s during colitis","volume":"5","author":"Bauch\u00e9","year":"2020","journal-title":"Sci Immunol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13075-022-02769-y","article-title":"Impaired activation of STAT5 upon IL-2 stimulation in Tregs and elevated sIL-2R in Sj\u00f6gren\u2019s syndrome","volume":"24","author":"Keindl","year":"2022","journal-title":"Arthritis Res Ther"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2000612","article-title":"Dynamic roles for IL-2-STAT5 signaling in effector and regulatory CD4+ T cell populations","volume":"205","author":"Jones","year":"2020","journal-title":"J Immunol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1010913","article-title":"IL-2\u2013mTORC1 signaling coordinates the STAT1\/T-bet axis to ensure Th1 cell differentiation and anti-bacterial immune response in fish","volume":"18","author":"Ai","year":"2022","journal-title":"PloS Pathog"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1038\/s44318-024-00235-w","article-title":"Acidity suppresses CD8\u2009+\u2009T-cell function by perturbing IL-2, mTORC1, and c-Myc signaling","volume":"43","author":"Vuillefroy de Silly","year":"2024","journal-title":"EMBO J"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-06-095182","article-title":"IL-2\u2013 and IL-15\u2013induced activation of the rapamycin-sensitive mTORC1 pathway in Malignant CD4+ T lymphocytes","volume":"111","author":"Marzec","year":"2008","journal-title":"Blood"},{"key":"B63","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/nature12297","article-title":"mTORC1 couples immune signals and metabolic programming to establish Treg cell function","volume":"499","author":"Zeng","year":"2013","journal-title":"Nature"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1203\/00006450-199903000-00020","article-title":"Defective IL2 gene expression in newborn is accompanied with impaired tyrosine-phosphorylation in T cells","volume":"45","author":"Ansart-Pirenne","year":"1999","journal-title":"Pediatr Res"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3803\/EnM.2018.33.2.175","article-title":"Genome-wide association studies of autoimmune thyroid diseases, thyroid function, and thyroid cancer","volume":"33","author":"Hwangbo","year":"2018","journal-title":"Endocrinol Metab (Seoul)"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2023.2238600","article-title":"Retrospective analysis of low-dose interleukin-2 therapy on chronic autoimmune thyroid disease with concurrent systemic lupus erythematosus","volume":"55","author":"Wang","year":"2023","journal-title":"Ann Med"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4148","article-title":"Low-dose interleukin-2 treatment selectively modulates CD4(+) T cell subsets in patients with systemic lupus erythematosus","volume":"22","author":"He","year":"2016","journal-title":"Nat Med"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-214229","article-title":"Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial","volume":"78","author":"Rosenzwajg","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215396","article-title":"Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial","volume":"79","author":"He","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-021-00301-3","article-title":"Treatment of active idiopathic inflammatory myopathies by low-dose interleukin-2: A prospective cohort pilot study","volume":"8","author":"Miao","year":"2021","journal-title":"Rheumatol Ther"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022016322","article-title":"STAT5 activation promotes progression and chemotherapy resistance in early T-cell precursor acute lymphoblastic leukemia","volume":"142","author":"Tremblay","year":"2023","journal-title":"Blood"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2010.02.004","article-title":"STAT5 in B cell development and leukemia","volume":"22","author":"Malin","year":"2010","journal-title":"Curr Opin Immunol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/ni.3716","article-title":"STAT5 antagonism of B cell enhancer networks drives leukemia and poor patient survival","volume":"18","author":"Katerndahl","year":"2017","journal-title":"Nat Immunol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-023-01078-x","article-title":"SEL1L preserves CD8+ T-cell survival and homeostasis by fine-tuning PERK signaling and the IL-15 receptor-mediated mTORC1 axis","volume":"20","author":"Gao","year":"2023","journal-title":"Cell Mol Immunol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06733-x","article-title":"Single-cell CRISPR screens in vivo map T cell fate regulomes in cancer","volume":"624","author":"Zhou","year":"2023","journal-title":"Nature"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-018-0185-x","article-title":"Sin1\/mTORC2 regulate B cell growth and metabolism by activating mTORC1 and Myc","volume":"16","author":"Li","year":"2019","journal-title":"Cell Mol Immunol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1038\/s41418-021-00775-2","article-title":"CCL2 regulation of MST1-mTOR-STAT1 signaling axis controls BCR signaling and B-cell differentiation","volume":"28","author":"Yang","year":"2021","journal-title":"Cell Death Differentiation"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1002\/kjm2.12414","article-title":"Genetic polymorphisms of regulatory T cell-related genes modulate systemic inflammation induced by viral hepatitis","volume":"37","author":"Kao","year":"2021","journal-title":"Kaohsiung J Med Sci"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2024.06.006","article-title":"The pros and confs of IL-18 activation","volume":"57","author":"Clancy","year":"2024","journal-title":"Immunity"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0602313","article-title":"Interleukin-18","volume":"73","author":"Gracie","year":"2003","journal-title":"J Leukocyte Biol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.919973","article-title":"Interleukin-18 cytokine in immunity, inflammation, and autoimmunity: Biological role in induction, regulation, and treatment","volume":"13","author":"Ihim","year":"2022","journal-title":"Front Immunol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejcb.2008.06.004","article-title":"Pathophysiological roles of osteoprotegerin (OPG)","volume":"88","author":"Reid","year":"2009","journal-title":"Eur J Cell Biol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2021.107941","article-title":"The role of osteoprotegerin (OPG) in fibrosis: its potential as a biomarker and\/or biological target for the treatment of fibrotic diseases","volume":"228","author":"Habibie","year":"2021","journal-title":"Pharmacol Ther"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20030705","article-title":"The role of osteoprotegerin and its ligands in vascular function","volume":"20","author":"Rochette","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B85","first-page":"281","article-title":"Congenital hypothyroidism and nephrocalcinosis","volume":"47","author":"Mantan","year":"2010","journal-title":"Indian Pediatr"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1292\/jvms.20-0391","article-title":"Severe calcification of systemic blood vessel walls caused by continuous hypercalcemia in a cat with congenital hypothyroidism","volume":"82","author":"Tanaka","year":"2020","journal-title":"J Vet Med Sci"},{"key":"B87","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0198-8859(99)00170-6","article-title":"2B4: an NK cell activating receptor with unique specificity and signal transduction mechanism","volume":"61","author":"Nakajima","year":"2000","journal-title":"Hum Immunol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa905","article-title":"Redefining congenital hypothyroidism","volume":"106","author":"Van Vliet","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2020.05.005","article-title":"Treatment discontinuation by 3 years after levothyroxine initiation among children diagnosed with congenital hypothyroidism","volume":"223","author":"Kemper","year":"2020","journal-title":"J Pediatr"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1608098\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T05:43:56Z","timestamp":1760507036000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1608098\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":89,"alternative-id":["10.3389\/fimmu.2025.1608098"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1608098","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,15]]},"article-number":"1608098"}}